Human fear acquisition deficits in relation to genetic variants of the corticotropin-releasing hormone receptor 1 and the serotonin transporter - revisited

Genes, Brain and Behavior

Volumn 15, Issue 2, 2016, Pages 209-220

  Heitland, I ^a,b   Groenink, L ^c   van Gool, J M ^a   Domschke, K ^d   Reif, A ^e   Baas, J M P ^a,b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

^d UNIVERSITY OF WÜRZBURG   (Germany)

^e UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Corticotropin releasing factor; Corticotropin releasing hormone; CRHR1; Fear conditioning; Fear potentiated startle; Replication study; Rs878886

Indexed keywords

CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; SEROTONIN TRANSPORTER; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR;

ADULT; ALLELE; ANXIETY; ARTICLE; ASSOCIATION; FEAR; FEAR CONDITIONING TEST; FEMALE; GENETIC VARIABILITY; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; REPLICATION STUDY; VIRTUAL REALITY; ANXIETY DISORDER; CONDITIONED REFLEX; GENETIC POLYMORPHISM; GENETICS; METABOLISM; PHYSIOLOGY; YOUNG ADULT;

ADULT; ANXIETY; ANXIETY DISORDERS; CONDITIONING, CLASSICAL; CORTICOTROPIN-RELEASING HORMONE; FEAR; FEMALE; HUMANS; MALE; POLYMORPHISM, GENETIC; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; YOUNG ADULT;

EID: 84956802022     PISSN: 16011848     EISSN: 1601183X     Source Type: Journal    
DOI: 10.1111/gbb.12276     Document Type: Article

References (74)

1. Baas, J.M.P. (2013) Individual differences in predicting aversive events and modulating contextual anxiety in a context and cue conditioning paradigm. Biol Psychol 92, 17-25.
2. Baas, J.M.P. & Heitland, I. (2014) The impact of cue learning, trait anxiety and genetic variation in the serotonin 1A receptor on contextual fear. Int J Psychophysiol 14, 1-9.
3. Baas, J.M.P., van Ooijen, L., Goudriaan, A. & Kenemans, J.L. (2008) Failure to condition to a cue is associated with sustained contextual fear. Acta Psychol 127, 581-592.
4. Bailey, J.E., Papadopoulos, A., Diaper, A., Phillips, S., Schmidt, M., van der Ark, P., Dourish, C.T., Dawson, G.R. & Nutt, D.J. (2011) Preliminary evidence of anxiolytic effects of the CRF(1) receptor antagonist R317573 in the 7.5% CO(2) proof-of-concept experimental model of human anxiety. J Psychopharmacol 25, 1199-1206.
5. Baker, D.G., West, S.A., Nicholson, W.E., Ekhator, N.N., Kasckow, J.W., Hill, K.K., Bruce, A.B., Orth, D.N. & Geracioti, T.D. (1999) Serial CSF corticotropin-releasing hormone levels and adrenocortical activity in combat veterans with posttraumatic stress disorder. Am J Psychiatry 156, 585-588.
6. Bijlsma, E.Y., van Leeuwen, M.L.F., Westphal, K.G.C., Olivier, B. & Groenink, L. (2011) Local repeated corticotropin-releasing factor infusion exacerbates anxiety- and fear-related behavior: differential involvement of the basolateral amygdala and medial prefrontal cortex. Neuroscience 173, 82-92.
7. Bijlsma, E.Y., Hendriksen, H., Baas, J.M.P., Millan, M.J. & Groenink, L. (2015) Lifelong disturbance of serotonin transporter functioning results in fear learning deficits: reversal by blockade of CRF1 receptors. Eur Neuropsychopharmacol 25, 1733-1743.
8. Binder, E.B. & Nemeroff, C.B. (2010) The CRF system, stress, depression and anxiety-insights from human genetic studies. Mol Psychiatry 15, 574-588.
9. Bissette, G., Klimek, V., Pan, J., Stockmeier, C. & Ordway, G. (2003) Elevated concentrations of CRF in the locus coeruleus of depressed subjects. Neuropsychopharmacology 28, 1328-1335.
10. Blumenthal, T.D., Cuthbert, B.N., Filion, D.L., Hackley, S., Lipp, O.V. & van Boxtel, A. (2005) Committee report: guidelines for human startle eyeblink electromyographic studies. Psychophysiology 42, 1-15.
11. Bogdan, R., Hyde, L.W. & Hariri, A.R. (2013) A neurogenetics approach to understanding individual differences in brain, behavior, and risk for psychopathology. Mol Psychiatry 18, 288-299.
12. Button, K.S., Ioannidis, J.P.A., Mokrysz, C., Nosek, B.A., Flint, J., Robinson, E.S.J. & Munafò, M.R. (2013a) Power failure: why small sample size undermines the reliability of neuroscience. Nat Rev Neurosci 14, 365-376.
13. Button, K.S., Ioannidis, J.P.A., Mokrysz, C., Nosek, B.A., Flint, J., Robinson, E.S.J. & Munafò, M.R. (2013b) Confidence and precision increase with high statistical power. Nat Rev Neurosci 14, 585.
14. Campeau, S., Falls, W.A., Cullinan, W.E., Helmreich, D.L., Davis, M. & Watson, S.J. (1997) Elicitation and reduction of fear: behavioural and neuroendocrine indices and brain induction of the immediate-early gene c-fos. Neuroscience 78, 1087-1104.
15. Costa, P.T. Jr. & McCrae, R.R. (1992) Revised NEO Personality Inventory (NEO-PI-R) and NEO Five-Factor Inventory (NEO-FFI) Professional Manual. Psychological Assessment Resources, Odessa, FL.
16. Davis, M. (2006) Neural systems involved in fear and anxiety measured with fear-potentiated startle. Am Psychol 61, 741-756.
17. Davis, M., Antoniadis, E.A., Amaral, D.G. & Winslow, J.T. (2008) Acoustic startle reflex in rhesus monkeys: a review. Rev Neurosci 19, 171-185.
18. Davis, M., Walker, D.L., Miles, L. & Grillon, C. (2010) Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety. Neuropsychopharmacology 35, 105-135.
19. Duits, P., Cath, D.C., Lissek, S., Hox, J.J., Hamm, A.O., Engelhard, I.M., van den Hout, M.A. & Baas, J.M.P. (2015) Updated meta-analysis of classical fear conditioning in the anxiety disorders. Depress Anxiety 32, 239-253.
20. Flint, J. & Munafò, M.R. (2013) Candidate and non-candidate genes in behavior genetics. Curr Opin Neurobiol 23, 57-61.
21. Forster, G.L., Pringle, R.B., Mouw, N.J., Vuong, S.M., Watt, M.J., Burke, A.R., Lowry, C.A., Summers, C.H. & Renner, K.J. (2008) Corticotropin-releasing factor in the dorsal raphe nucleus increases medial prefrontal cortical serotonin via type 2 receptors and median raphe nucleus activity. Eur J Neurosci 28, 299-310.
22. Fox, J.H. & Lowry, C.A. (2013) Corticotropin-releasing factor-related peptides, serotonergic systems, and emotional behavior. Front Neurosci 7, 169.
23. Gloster, A.T., Gerlach, A.L., Hamm, A., Höfler, M., Alpers, G.W., Kircher, T., Ströhle, A., Lang, T., Wittchen, H.-U., Deckert, J. & Reif, A. (2015) 5HTT is associated with the phenotype psychological flexibility: results from a randomized clinical trial. Eur Arch Psychiatry Clin Neurosci 265, 399-406.
24. Griebel, G. & Holsboer, F. (2012) Neuropeptide receptor ligands as drugs for psychiatric diseases: the end of the beginning? Nat Rev Drug Discov 11, 462-478.
25. Grillon, C. (2002) Associative learning deficits increase symptoms of anxiety in humans. Biol Psychiatry 51, 851-858.
26. Grillon, C., Hale, E., Lieberman, L., Davis, A., Pine, D.S. & Ernst, M. (2015) The CRH1 antagonist GSK561679 increases human fear but not anxiety as assessed by startle. Neuropsychopharmacology 40, 1064-1071.
27. Hammack, S.E., Schmid, M.J., LoPresti, M.L., Der-Avakian, A., Pellymounter, M.A., Foster, A.C., Watkins, L.R. & Maier, S.F. (2003) Corticotropin releasing hormone type 2 receptors in the dorsal raphe nucleus mediate the behavioral consequences of uncontrollable stress. J Neurosci 23, 1019-1025.
28. Haufler, D., Nagy, F.Z. & Paré, D. (2013) Neuronal correlates of fear conditioning in the bed nucleus of the stria terminalis. Learn Mem 20, 633-641.
29. Hauger, R.L., Risbrough, V., Brauns, O. & Dautzenberg, F.M. (2006) Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets. CNS Neurol Disord Drug Targets 5, 453-479.
30. Hauger, R.L., Risbrough, V., Oakley, R.H., Olivares-Reyes, J.A. & Dautzenberg, F.M. (2009) Role of CRF receptor signaling in stress vulnerability, anxiety, and depression. Ann N Y Acad Sci 1179, 120-143.
31. Heitland, I., Klumpers, F., Oosting, R.S., Evers, D.J.J., Kenemans, J.L. & Baas, J.M.P. (2012) Failure to extinguish fear and genetic variability in the human cannabinoid receptor 1. Transl Psychiatry 2, e162-e169.
32. Heitland, I., Groenink, L., Bijlsma, E.Y., Oosting, R.S. & Baas, J.M.P. (2013) Human fear acquisition deficits in relation to genetic variants of the corticotropin releasing hormone receptor 1 and the serotonin transporter. PLoS One 8, e63772.
33. Homberg, J.R. & Contet, C. (2009) Deciphering the interaction of the corticotropin-releasing factor and serotonin brain systems in anxiety-related disorders. J Neurosci 29, 13743-13745.
34. Hsu, D.T., Mickey, B.J., Langenecker, S.A., Heitzeg, M.M., Love, T.M., Wang, H., Kennedy, S.E., Peciña, M., Shafir, T., Hodgkinson, C.A., Enoch, M.-A., Goldman, D. & Zubieta, J.-K. (2012) Variation in the corticotropin-releasing hormone receptor 1 (CRHR1) gene influences fMRI signal responses during emotional stimulus processing. J Neurosci 32, 3253-3260.
35. Hu, X.-Z., Lipsky, R.H., Zhu, G., Akhtar, L.A., Taubman, J., Greenberg, B.D., Xu, K., Arnold, P.D., Richter, M.A., Kennedy, J.L., Murphy, D.L. & Goldman, D. (2006) Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am J Hum Genet 78, 815-826.
36. Ioannidis, J.P.A., Munafò, M.R., Fusar-Poli, P., Nosek, B.A. & David, S.P. (2014) Publication and other reporting biases in cognitive sciences: detection, prevalence, and prevention. Trends Cogn Sci 18, 235-241.
37. Ishitobi, Y., Nakayama, S., Yamaguchi, K., Kanehisa, M., Higuma, H., Maruyama, Y., Ninomiya, T., Okamoto, S., Tanaka, Y., Tsuru, J., Hanada, H., Isogawa, K. & Akiyoshi, J. (2012) Association of CRHR1 and CRHR2 with major depressive disorder and panic disorder in a Japanese population. Am J Med Genet B Neuropsychiatr Genet 159B, 429-436.
38. Jasny, B.R., Chin, G., Chong, L. & Vignieri, S. (2011) Data replication & reproducibility. Again, and again, and again ... Introduction. Science 334, 1225.
39. Keck, M.E., Kern, N., Erhardt, A., Unschuld, P.G., Ising, M., Salyakina, D., Müller, M.B., Knorr, C.C., Lieb, R., Hohoff, C., Krakowitzky, P., Maier, W., Bandelow, B., Fritze, J., Deckert, J., Holsboer, F., Müller-Myhsok, B. & Binder, E.B. (2008) Combined effects of exonic polymorphisms in CRHR1 and AVPR1B genes in a case/control study for panic disorder. Am J Med Genet B Neuropsychiatr Genet 147B, 1196-1204.
40. Kirby, L.G., Freeman-Daniels, E., Lemos, J.C., Nunan, J.D., Lamy, C., Akanwa, A. & Beck, S.G. (2008) Corticotropin-releasing factor increases GABA synaptic activity and induces inward current in 5-hydroxytryptamine dorsal raphe neurons. J Neurosci 28, 12927-12937.
41. Klumpers, F., Raemaekers, M.A.H.L., Ruigrok, A.N.V., Hermans, E.J., Kenemans, J.L. & Baas, J.M.P. (2010a) Prefrontal mechanisms of fear reduction after threat offset. Biol Psychiatry 68, 1031-1038.
42. Klumpers, F., van Gerven, J.M., Prinssen, E.P., Niklson, I., Roesch, F., Riedel, W.J., Kenemans, J.L. & Baas, J.M.P. (2010b) Method development studies for repeatedly measuring anxiolytic drug effects in healthy humans. J Psychopharmacol 24, 657-666.
43. Klumpers, F., Heitland, I., Oosting, R.S., Kenemans, J.L. & Baas, J.M.P. (2011) Genetic variation in serotonin transporter function affects human fear expression indexed by fear-potentiated startle. Biol Psychol 89, 277-282.
44. Klumpers, F., Kroes, M.C., Heitland, I., Everaerd, D., Akkermans, S.E.A., Oosting, R.S., van Wingen, G., Franke, B., Kenemans, J.L., Fernández, G. & Baas, J.M.P. (2014) Dorsomedial prefrontal cortex mediates the impact of serotonin transporter linked polymorphic region genotype on anticipatory threat reactions. Biol Psychiatry 78, 582-589.
45. Lakens, D., Haans, A. & Koole, S.L. (2012) Één onderzoek is géén onderzoek: Het belang van replicaties voor de psychologische wetenschap (One study is no study: The importance of replication for psychological science). De Psycholoog 9, 10-18.
46. Lee, Y. & Davis, M. (1997) Role of the hippocampus, the bed nucleus of the stria terminalis, and the amygdala in the excitatory effect of corticotropin-releasing hormone on the acoustic startle reflex. J Neurosci 17, 6434-6446.
47. Liang, K.C. & Lee, E.H. (1988) Intra-amygdala injections of corticotropin releasing factor facilitate inhibitory avoidance learning and reduce exploratory behavior in rats. Psychopharmacology (Berl) 96, 232-236.
48. Lonsdorf, T.B., Baas, J.M.P. (2015) Genetics in experimental psychopathology: From laboratory models to clinical applications. Where do we go from here? Psychopathol Review, In Press. URL http://pr.textrum.com/index.php?art_id=42#.VkCEtISlDNc (Date of last access November 2015).
49. Lonsdorf, T.B., Weike, A.I., Nikamo, P., Schalling, M., Hamm, A.O. & Ohman, A. (2009) Genetic gating of human fear learning and extinction: possible implications for gene-environment interaction in anxiety disorder. Psychol Sci 20, 198-206.
50. Lowry, C.A. & Moore, F.L. (2006) Regulation of behavioral responses by corticotropin-releasing factor. Gen Comp Endocrinol 146, 19-27.
51. Lukkes, J., Vuong, S., Scholl, J., Oliver, H. & Forster, G. (2009) Corticotropin-releasing factor receptor antagonism within the dorsal raphe nucleus reduces social anxiety-like behavior after early-life social isolation. J Neurosci 29, 9955-9960.
52. Makel, M.C., Plucker, J.A. & Hegarty, B. (2012) Replications in psychology research how often do they really occur? Perspect Psychol Sci 7, 537-542.
53. Meyer-Lindenberg, A. (2012) The future of fMRI and genetics research. Neuroimage 62, 1286-1292.
54. Munafò, M.R. & Gage, S.H. (2013) Improving the reliability and reporting of genetic association studies. Drug Alcohol Depend 132, 411-413.
55. Munafò, M.R., Brown, S.M. & Hariri, A.R. (2008) Serotonin transporter (5-HTTLPR) genotype and amygdala activation: a meta-analysis. Biol Psychiatry 63, 852-857.
56. Nakamura, M., Ueno, S., Sano, A. & Tanabe, H. (2000) The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants. Mol Psychiatry 5, 32-38.
57. Pavlov, I. (1927) Conditioned Reflexes: An Investigation of the Physiological Activity of the Cerebral Cortex. Oxford University Press, London.
58. Praschak-Rieder, N., Kennedy, J., Wilson, A.A., Hussey, D., Boovariwala, A., Willeit, M., Ginovart, N., Tharmalingam, S., Masellis, M., Houle, S. & Meyer, J.H. (2007) Novel 5-HTTLPR allele associates with higher serotonin transporter binding in putamen: a [(11)C] DASB positron emission tomography study. Biol Psychiatry 62, 327-331.
59. Raadsheer, F.C., Hoogendijk, W.J., Stam, F.C., Tilders, F.J. & Swaab, D.F. (1994) Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology 60, 436-444.
60. Reul, J.M.H.M. & Holsboer, F. (2002) On the role of corticotropin-releasing hormone receptors in anxiety and depression. Dialogues Clin Neurosci 4, 31-46.
61. Risbrough, V.B. & Stein, M.B. (2006) Role of corticotropin releasing factor in anxiety disorders: a translational research perspective. Horm Behav 50, 550-561.
62. Risbrough, V.B., Geyer, M.A., Hauger, R.L., Coste, S., Stenzel-Poore, M., Wurst, W. & Holsboer, F. (2009) CRF1 and CRF2 receptors are required for potentiated startle to contextual but not discrete cues. Neuropsychopharmacology 34, 1494-1503.
63. Roozendaal, B., Brunson, K.L., Holloway, B.L., McGaugh, J.L. & Baram, T.Z. (2002) Involvement of stress-released corticotropin-releasing hormone in the basolateral amygdala in regulating memory consolidation. Proc Natl Acad Sci U S A 99, 13908-13913.
64. Roozendaal, B., Schelling, G. & McGaugh, J.L. (2008) Corticotropin-releasing factor in the basolateral amygdala enhances memory consolidation via an interaction with the beta-adrenoceptor-cAMP pathway: dependence on glucocorticoid receptor activation. J Neurosci 28, 6642-6651.
65. Sautter, F.J., Bissette, G., Wiley, J., Manguno-Mire, G., Schoenbachler, B., Myers, L., Johnson, J.E., Cerbone, A. & Malaspina, D. (2003) Corticotropin-releasing factor in posttraumatic stress disorder (PTSD) with secondary psychotic symptoms, nonpsychotic PTSD, and healthy control subjects. Biol Psychiatry 54, 1382-1388.
66. Simmons, J.P., Nelson, L.D. & Simonsohn, U. (2011) False-positive psychology: undisclosed flexibility in data collection and analysis allows presenting anything as significant. Psychol Sci 22, 1359-1366.
67. Simons, D.J. (2014) The value of direct replication. Perspect Psychol Sci 9, 76-80.
68. Spielberger, D.C., Gorsuch, L.R. & Lushene, R.E. (1970) Manual for the State-Trait Anxiety Inventory. Consulting Psychologists Press, Palo Alto, CA.
69. Valentino, R.J., Lucki, I. & Van Bockstaele, E. (2010) Corticotropin-releasing factor in the dorsal raphe nucleus: linking stress coping and addiction. Brain Res 1314, 29-37.
70. Van der Ploeg, D.M. (1980) Handleiding bij de Zelf-Beoordelings Vragenlijst, ZBV. Een Nederlandstalige bewerking van de Spielberger State-Trait Anxiety Inventory, STAT-DY. Swets en Zeitlinger, Lisse.
71. Waselus, M., Nazzaro, C., Valentino, R.J. & Van Bockstaele, E.J. (2009) Stress-induced redistribution of corticotropin-releasing factor receptor subtypes in the dorsal raphe nucleus. Biol Psychiatry 66, 76-83.
72. Weber, H., Richter, J., Straube, B., Lueken, U., Domschke, K., Schartner, C., Klauke, B., Baumann, C., Pane-Farre, C., Jacob, C.P., Scholz, C., Zwanzger, P., Lang, T., Fehm, L., Jansen, A., Konrad, C., Fydrich, T., Wittmann, A., Pfleiderer, B., Ströhle, A., Gerlach, A.L., Alpers, G.W., Arolt, V., Pauli, P., Wittchen, H.-U., Kent, L., Hamm, A., Kircher, T., Deckert, J., Reif, A. (2015) Allelic variation in CRHR1 predisposes to panic disorder: evidence for biased fear processing. Mol Psychiatry, In Press. URL http://www.nature.com/mp/journal/vaop/ncurrent/pdf/mp2015125a.pdf (Date of last access November 2015).
73. Wendland, J.R., Martin, B.J., Kruse, M.R., Lesch, K.-P. & Murphy, D.L. (2006) Simultaneous genotyping of four functional loci of human SLC6A4, with a reappraisal of 5-HTTLPR and rs25531. Mol Psychiatry 11, 224-226.
74. Wolpe, J. & Rowan, V.C. (1988) Panic disorder: a product of classical conditioning. Behav Res Ther, 26, 441-450.